Challenges in Taxing E-Cigarettes and HNB Products in South Africa

Regulations by 2FIRSTS.ai
Jan.08.2024
Challenges in Taxing E-Cigarettes and HNB Products in South Africa
The taxation model of electronic nicotine delivery systems (ENDS) and HnB products poses challenges for the South African government.

According to South African media outlet allafrica, on January 7, it was reported that the electronic nicotine delivery systems (ENDS) or e-cigarettes, as well as heat-not-burn (HnB) products, have presented a challenge to the tax regime of the South African government. Economists and medical health experts have differing opinions on the design of tobacco and nicotine taxation.

 

South Africa has become a case study that reflects the global disparities as the country reevaluates its taxation policies on tobacco and nicotine.

 

Marius van Oort, an associate professor at Teplya University, has pointed out that although e-cigarettes and HnB devices do not contain tobacco, they still contain addictive nicotine. Therefore, whether it is appropriate to apply the same tax rate to these products, which are different from traditional combustible tobacco, remains uncertain.

 

In a recent paper, Van Oort argues for the implementation of risk-based tax rates, which would set tax rates based on the degree of harm various products pose to health. This would require reliance on scientific evidence. He points out that governments need to balance several aspects when setting tax policy, including ensuring sufficient tax revenue, reducing negative health impacts, promoting economic and social development, and gaining political acceptance in a democratic society.

 

South Africa stands out as a noteworthy case, due to its significant income and wealth inequality issues, underperforming public healthcare system, and high prevalence of non-communicable diseases, particularly among low-income populations. Farnsworth ultimately suggests that given South Africa's current economic situation and health needs, implementing taxation based on the risks associated with tobacco and nicotine products may be the most appropriate strategy.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
New E-Cigarette Law Takes Effect in Texas in September: Complete Ban on Marijuana Vape Sales, Violators Face Up to One Year in Prison
New E-Cigarette Law Takes Effect in Texas in September: Complete Ban on Marijuana Vape Sales, Violators Face Up to One Year in Prison
Starting September 1st, Texas banned the sale of THC-containing e-cigarettes. Violators face up to $4,000 in fines and one year in jail. Supporters say it helps keep marijuana vapes out of teens' hands. But opponents fear it will push people to dangerous alternatives. Some businesses, like Gruene Botanicals, argue that these vapes are important for treating chronic pain and PTSD, and a total ban could lead consumers to the black market.
Sep.02 by 2FIRSTS.ai
BAT appoints Matthew Wright as Independent Non-Executive Director, effective November 1, 2025
BAT appoints Matthew Wright as Independent Non-Executive Director, effective November 1, 2025
Matthew Wright appointed as independent non-executive director of British American Tobacco, effective November 1, bringing extensive international executive experience.
Oct.15 by 2FIRSTS.ai
Operation Shutdown in South Australia closes 71 illegal tobacco and e-cigarette stores, confiscates over $4.2 million worth of products
Operation Shutdown in South Australia closes 71 illegal tobacco and e-cigarette stores, confiscates over $4.2 million worth of products
South Australia cracked down on illegal tobacco and e-cigarette sales, closed 71 illegal stores, and seized A$4.2 million (about US$2.77 million) worth of products.
Sep.30 by 2FIRSTS.ai
InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
2Firsts’ on-site reporting at InterTabac 2025 in Dortmund, Germany, found that BAT showcased a range of HTP, e-vapor, and nicotine pouch products, with a focus on zero-nicotine e-vapor and the VUSE Ultra line, and set up an interactive experience area.
Sep.19 by 2FIRSTS.ai
Approximately $10,000 worth of counterfeit goods, including Labubu and e-cigarettes, were seized in Ley, UK
Approximately $10,000 worth of counterfeit goods, including Labubu and e-cigarettes, were seized in Ley, UK
Greater Manchester Police and Trading Standards raided two shops in Leigh, seizing £10,000 worth of illegal goods — mainly counterfeit Labubu toys, cigarettes, and e-cigarettes. The operation, under the "Safe4Summer" initiative, targets products that risk public health and safety. One suspect attempted to flee but was caught. Authorities are continuing to investigate and have urged the public to share any relevant information.
Sep.15 by 2FIRSTS.ai